[
  {
    "ts": null,
    "headline": "Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out",
    "summary": "Protagonist Therapeutics broke out Monday after the company's drug topped its rival from Bristol in a psoriasis study.",
    "url": "https://finnhub.io/api/news?id=62dc2759f240cea1962b6f60cd16b18bc40e768baea3778f1df99db3cb10ea61",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741638646,
      "headline": "Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out",
      "id": 133184496,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Protagonist Therapeutics broke out Monday after the company's drug topped its rival from Bristol in a psoriasis study.",
      "url": "https://finnhub.io/api/news?id=62dc2759f240cea1962b6f60cd16b18bc40e768baea3778f1df99db3cb10ea61"
    }
  },
  {
    "ts": null,
    "headline": "Is AbbVie Inc. (ABBV) the Best Performing Dividend Stock to Buy Now?",
    "summary": "We recently compiled a list of the 14 Best Performing Dividend Stocks To Buy Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other dividend stocks. Dividend stocks have taken a backseat in the market as technology and AI-driven equities have soared to record highs. However, […]",
    "url": "https://finnhub.io/api/news?id=b9af40614bf282ead64d9dee405e867c6e02c491a4757236af1745f0213bb9bc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741635636,
      "headline": "Is AbbVie Inc. (ABBV) the Best Performing Dividend Stock to Buy Now?",
      "id": 133184497,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 14 Best Performing Dividend Stocks To Buy Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other dividend stocks. Dividend stocks have taken a backseat in the market as technology and AI-driven equities have soared to record highs. However, […]",
      "url": "https://finnhub.io/api/news?id=b9af40614bf282ead64d9dee405e867c6e02c491a4757236af1745f0213bb9bc"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=8b35611a6f2e6693199bb156250a0ff486f1d10e8c841d49e4b117861ef234b8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741624320,
      "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "id": 133133179,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=8b35611a6f2e6693199bb156250a0ff486f1d10e8c841d49e4b117861ef234b8"
    }
  },
  {
    "ts": null,
    "headline": "Zacks Market Edge Highlights: Berkshire Hathaway, Aon plc and AbbVie",
    "summary": "Berkshire Hathaway, Aon plc and AbbVie are part of the Zacks Market Edge article.",
    "url": "https://finnhub.io/api/news?id=fa5e5a6aeb750a15ea9b4278fbe8e94ddc6f19a00fea5640b20d5066aa2507db",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741618020,
      "headline": "Zacks Market Edge Highlights: Berkshire Hathaway, Aon plc and AbbVie",
      "id": 133184498,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Berkshire Hathaway, Aon plc and AbbVie are part of the Zacks Market Edge article.",
      "url": "https://finnhub.io/api/news?id=fa5e5a6aeb750a15ea9b4278fbe8e94ddc6f19a00fea5640b20d5066aa2507db"
    }
  },
  {
    "ts": null,
    "headline": "This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy?",
    "summary": "It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss market.  Brands such as Wegovy and Zepbound -- the leading anti-obesity therapies -- are now well known and are generating billions of dollars in annual sales.  AbbVie (NYSE: ABBV) is one of them.",
    "url": "https://finnhub.io/api/news?id=34116c3097d4cdcd74137f113f7c83fedfda75913587a4a16e25d07b001000d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741607820,
      "headline": "This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy?",
      "id": 133184500,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss market.  Brands such as Wegovy and Zepbound -- the leading anti-obesity therapies -- are now well known and are generating billions of dollars in annual sales.  AbbVie (NYSE: ABBV) is one of them.",
      "url": "https://finnhub.io/api/news?id=34116c3097d4cdcd74137f113f7c83fedfda75913587a4a16e25d07b001000d4"
    }
  },
  {
    "ts": null,
    "headline": "4 February Raises Includes AES Corporation's 6.2% Yield",
    "summary": "Rose's Income Garden achieved a near all-time high with a 5.9% yield. Learn why AES Corp and Mastercard are buys, while AbbVie and BMY are holds.",
    "url": "https://finnhub.io/api/news?id=0ae6ec35b38fca716fef829bcb0b98681e5669f59a5d8e4b85548afc64ed9cf8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741606641,
      "headline": "4 February Raises Includes AES Corporation's 6.2% Yield",
      "id": 133121732,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160750173/image_2160750173.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Rose's Income Garden achieved a near all-time high with a 5.9% yield. Learn why AES Corp and Mastercard are buys, while AbbVie and BMY are holds.",
      "url": "https://finnhub.io/api/news?id=0ae6ec35b38fca716fef829bcb0b98681e5669f59a5d8e4b85548afc64ed9cf8"
    }
  }
]